Altre lingue Bliss GVS Pharma Limited NSE India S.E.

Azioni

BLISSGVS

INE416D01022

Mercato chiuso - NSE India S.E. Altri mercati azionari 13:40:29 16/07/2024			Variaz. 5gg	Var. 1 gen.
114,1 ^INR	-1,66%		+2,35%	-8,49%

20/06	Crisil mantiene il rating BBB+ sui prestiti bancari di Bliss GVS Pharma; prospettiva stabile	MT
02/05	Bliss GVS Pharma Limited riporta i risultati degli utili per l'intero anno terminato il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Office of the Joint Commissioner, Food and Drugs Administration Orders for Suspension of FDA License Issued to Tablet Division of Manufacturing Unit	21/06
Crisil Keeps BBB+ Rating on Bliss GVS Pharma's Bank Loans; Outlook Stable	20/06
Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	02/05
Bliss GVS Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	02/05
Bliss Gvs Pharma Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024, Payable on or Before August 24, 2024	02/05
Bliss GVS Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	23/01
Bliss GVS Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	01/11
Assistant Commission of State Tax Maharashtra, Mumbai Initiates Search At Certain Premises of Bliss GVS Pharma Limited	07/09/23
Bliss Gvs Pharma Limited Announces Change in the Designation of Mr. Vishal Vijay Rao	01/08/23
Bliss GVS Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	01/08/23
Bliss GVS Pharma Limited Declares Final Dividend for the Financial Year Ended March 31, 2023	19/07/23
Bliss GVS Pharma Gets Establishment Inspection Report from US FDA for Palghar, India Unit	15/06/23
Bliss Gvs Pharma Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023	11/05/23
Bliss GVS Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	11/05/23
Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023	11/05/23
Infomerics Keeps BBB Rating on Bliss GVS Pharma's Bank Financing; Outlook Stable	10/04/23
Bliss GVS Pharma Gets Three Observations from US FDA's Plant Inspection in Maharashtra, India	20/03/23
Bliss GVS Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	24/01/23
Bliss GVS Pharma Names New CFO	30/12/22
Bliss GVS Pharma Limited Appoints Mr. Deepak Sawant as Chief Financial Officer	30/12/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Bliss GVS Pharma Limited NSE India S.E.

Azioni

BLISSGVS

INE416D01022

Altre lingue

Filtri